Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Hospital Universitario La Paz - CIBERONC

11 abstracts

Abstract
Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801.
Org: Unidad Intercentros de Oncología, Hospitales Universitarios Regional y Virgen de la Victoria (HURyVV), Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Instituto Murciano de Investigación Sanitaria (IMIB), Hospital Universitario Clínico San Carlos,
Abstract
SELISARC: A Spanish Sarcoma Group (GEIS) phase I/II trial of selinexor plus gemcitabine in selected sarcoma subtypes—Results of the phase I part.
Org: Fundacion Jimenez Diaz University Hospital, Hospital Clinico San Carlos, Health Research Institute-Fundación Jiménez Díaz University Hospital, Hospital Universitario La Paz - CIBERONC, Hospital U. Miguel Servet,
Abstract
Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation.
Org: Vall d'Hebron Institute of Oncology, UGC Oncología Guipúzcoa, Hospital 12 de Octubre, Hospital Universitario Central de Asturias, Hospital Universitario Gregorio Marañón,
Abstract
Efficacy and safety of pembrolizumab (pembro) in children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) with slow early response (SER) to front-line chemotherapy (chemo) in the phase 2, open-label, KEYNOTE-667 study.
Org: IRCCS Ospedale Pediatrico Bambino Gesu, University College London Hospitals NHS Foundation Trust, Hospital Universitari Vall d Hebron, Regina Margherita Childrens Hospital and University of Turin, Turin, Italy, Princess Máxima Centrum,
Abstract
Efficacy and safety of mitazalimab in combination with mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): An interim analysis of the optimize-1 phase 1b/2 study.
Org: Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Cliniques Universitaires Saint-Luc, Department of Gastroenterology, Division of Digestive Oncology, Centre Léon Bérard,
Abstract
AXL pathway as a target to overcome resistance to PARP inhibitors in high-grade serous ovarian (HGSOC) and triple-negative breast cancer (TNBC) cell lines.
Org: Hospital Clinico Universitario de Valencia; INCLIVA; GEICAM Spanish Breast Cancer Group, INCLIVA-Biomedical Research Institute, CIBERONC - ISCIII, Instituto de Investigación Sanitaria (INCLIVA), Translational Oncology and Pathology Group,
Abstract
Spatially resolved multi-region transcriptomic subtyping and assessment of gene expression profiles associated with long-term benefit from chemo-immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC).
Org: Hospital Universitario 12 de Octubre, Hospital Teresa Herrera-Materno Infantil, Complejo Hospitalario Universitario A Coruna, Hospital Universitario Regional Málaga, Fundacion Jimenez Diaz University Hospital,
Abstract
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: Results from the observational study GEM1801.
Org: Hospital Universitario San Pedro de Alcántara, Unidad Intercentros de Oncología, Hospitales Universitarios Regional y Virgen de la Victoria (HURyVV), Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Universitari Vall d’Hebron y Vall Hebrón Institute of Oncology (VHIO),
Abstract
ASSESSMENT OF THE COVID-19 PANDEMIC FROM THE PERSPECTIVE OF PEOPLE WITH RHEUMATIC MUSCULOSKELETAL DISEASES IN EUROPE. RESULTS FROM THE REUMAVID STUDY (PHASE 1)
Org: Novartis Pharma AG, Hospital Universitario La Paz - CIBERONC, Universidad de Sevilla, Health & Territory Research (HTR), Sevilla, Spain, University of Leeds, Leeds Institute for Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom,
Abstract
AUTOANTIBODIES DETECTION IN AN EARLY ARTHRITIS CLINIC: DIAGNOSTIC VALUE FOR RHEUMATOID ARTHRITIS?
Org: Unit of Rheumatology, University of Padova, Department of Medicine, Padova, Italy, Hospital Santa Maria, Lisboa, Portugal, Service of Rheumatology,
Abstract
ASSOCIATION BETWEEN DISEASE ACTIVITY AND DAMAGE IN IDIOPATHIC INFLAMMATORY MYOPATHIES. DIFFERENCES BETWEEN INCIDENT AND PREVALENT CASES
Org: Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Unidad de Investigación, Sociedad Española de Reumatología, Madrid, Spain, Hospital del Mar, Barcelona, Spain,